Stockscreener 앱 받기
16.82
0.36%
0.06
시간 외 거래:
16.82
Zenas Biopharma Inc 주식(ZBIO)의 최신 뉴스
Will Zenas BioPharma Inc. price bounce be sustainable2025 Analyst Calls & Consistent Profit Trade Alerts - Newser
What makes Zenas BioPharma Inc. stock price move sharplyEarnings Beat & Technical Pattern Alert System - Newser
Sector ETF performance correlation with Zenas BioPharma Inc.2025 Price Momentum & AI Enhanced Trading Alerts - Newser
Published on: 2025-08-16 02:25:19 - Newser
Zenas BioPharma Inc.’s volatility index tracking explainedJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - Newser
What moving averages say about Zenas BioPharma Inc.2025 Dividend Review & Safe Capital Investment Plans - Newser
Zenas BioPharma (NASDAQ:ZBIO) Rating Lowered to Sell at Wall Street Zen - Defense World
Zenas BioPharma Q3 EPS Forecast Reduced by HC Wainwright - Defense World
Wedbush Analysts Cut Earnings Estimates for Zenas BioPharma - Defense World
Understanding Zenas BioPharma Inc.’s price movementJuly 2025 Retail & Free Reliable Trade Execution Plans - Newser
Zenas BioPharma Faces Legal and Financial Challenges Amid Securities Class Action Lawsuit - MSN
Measuring Zenas BioPharma Inc.’s beta against major indicesJuly 2025 Intraday Action & Long-Term Investment Growth Plans - Newser
Custom watchlist performance reports with Zenas BioPharma Inc.2025 Sector Review & Fast Exit/Entry Strategy Plans - Newser
Analyzing net buyer seller activity in Zenas BioPharma Inc.July 2025 Summary & Trade Opportunity Analysis Reports - Newser
When is the best time to exit Zenas BioPharma Inc.Weekly Loss Report & Reliable Intraday Trade Plans - Newser
Published on: 2025-08-15 16:40:47 - Newser
Is Zenas BioPharma Inc. a Top Dividend Stock to Watch in 2025Wall Street Watch & Verified Momentum Watchlists - Newser
Analyzing recovery setups for Zenas BioPharma Inc. investorsJuly 2025 Intraday Action & AI Enhanced Execution Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out - ACCESS Newswire
Zenas BioPharma (ZBIO) Expected to Announce Quarterly Earnings on Thursday - Defense World
Investigation announced for Investors who hold shares of Zenas - openPR.com
Buy Rating Affirmed for Zenas BioPharma: Promising Developments in Obexelimab Platform Drive Confidence - TipRanks
What Fibonacci levels say about Zenas BioPharma Inc. reboundPortfolio Return Summary & Weekly High Return Stock Opportunities - Newser
Zenas BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire
Zenas BioPharma Reports Q2 2025 Financial Results - TipRanks
Forecasting Zenas BioPharma Inc. price range with options dataTen-Year Sector Performance and Summary Analysis - Newser
Press Release: Zenas BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Updates - 富途牛牛
Zenas BioPharma Advances 3 Major Clinical Trials with $274M Cash Runway Through 2026 - Stock Titan
Zenas completes enrollment for Phase 2 trial of obexelimab for MS - Multiple Sclerosis News Today
Zenas BioPharma’s Growth Potential: Key Trials and Strategic Positioning Drive Buy Rating - TipRanks
Heatmap analysis for Zenas BioPharma Inc. and competitorsFree Watchlist for Smart Swing Trading - Newser
Zenas BioPharma Inc.’s Price Action Aligns with Quant SignalsConsistent Gain Investment Strategies Emerge - beatles.ru
Is Zenas BioPharma Inc. Stock a Smart Buy in 2025 Investment Analysis InsideVolume Confirmed Setup with Entry Confidence - Newser
Viridian Therapeutics, Inc.\DE SEC 10-Q Report - TradingView
Will Zenas BioPharma Inc. stock recover after recent drop5-Year Price Trend Summary and Analysis - Newser
How many analysts rate Zenas BioPharma Inc. as a “Buy”Get daily expert analysis on top stocks - Jammu Links News
Is Zenas BioPharma Inc. a growth stock or a value stockTriple-digit wealth increases - Jammu Links News
Zenas BioPharma Inc. Stock Analysis and ForecastInvest confidently with data-driven strategies - Jammu Links News
When is Zenas BioPharma Inc. stock expected to show significant growthUnlock exclusive trading strategies for gains - Jammu Links News
Is Zenas BioPharma Inc. a good long term investmentMaximize gains with professional stock picks - Jammu Links News
What are Zenas BioPharma Inc. company’s key revenue driversFree Daily Trading Room Entry - Jammu Links News
What are the latest earnings results for Zenas BioPharma Inc.Tremendous growth potential - Jammu Links News
Does Zenas BioPharma Inc. stock perform well during market downturnsSuperior trading gains - Jammu Links News
Is Zenas BioPharma Inc. stock overvalued or undervaluedExplosive earnings growth - Jammu Links News
Is it the right time to buy Zenas BioPharma Inc. stockMaximize portfolio value with smart investment plans - Jammu Links News
How strong is Zenas BioPharma Inc. company’s balance sheetInvest in stocks with strong fundamentals - Jammu Links News
What is the risk reward ratio of investing in Zenas BioPharma Inc. stockOutstanding capital returns - Jammu Links News
3 Highly Shorted Stocks That Could Be The Next Wall Street Sensations - Barchart.com
What are the technical indicators suggesting about Zenas BioPharma Inc.Daily Trading Guidance With Low Risk - Jammu Links News
0.41%
0.88%
자본화:
|
볼륨(24시간):